Why the vaccine rollout in the U.S. has been slower than expected
PBS, 24 Feb 2021
Editor’s note: Johnson & Johnson is a funder of the PBS NewsHour.
So far, 65 million Americans have received at least one shot of either the Pfizer or Moderna vaccines. As a country, the U.S. has recently picked up the pace of vaccinations, but there are concerns over supply and demand, which was the subject of a congressional hearing on Tuesday. Miles O'Brien joins John Yang to discuss.
Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6
Follow us:
Facebook: http://www.pbs.org/newshour
Twitter: http://www.twitter.com/newshour
Instagram: http://www.instagram.com/newshour
Subscribe:
PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts
Newsletters: https://www.pbs.org/newshour/subscribe
So far, 65 million Americans have received at least one shot of either the Pfizer or Moderna vaccines. As a country, the U.S. has recently picked up the pace of vaccinations, but there are concerns over supply and demand, which was the subject of a congressional hearing on Tuesday. Miles O'Brien joins John Yang to discuss.
Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6
Follow us:
Facebook: http://www.pbs.org/newshour
Twitter: http://www.twitter.com/newshour
Instagram: http://www.instagram.com/newshour
Subscribe:
PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts
Newsletters: https://www.pbs.org/newshour/subscribe
